article thumbnail

Human tumor response to novel natural product compounds using the POAI biobank and active machine learning

Predictive Oncology

Several NPDC compounds demonstrated efficacy across multiple tumor types and are now well positioned for further development. Given that the POAI platform provides a clinically relevant and accelerated pathway to natural compound screening. Complete the form below to download the white paper.

article thumbnail

August Monthly Momentum

KIF1A

Dr Verden’s Blog Post n-Lorem’s Press Release KIF1A-ASO-Article Download 2nd KAND patient receiving ASO treatment Meet Sloane. ” While the primary focus of CIRM grants has been cell therapy, it has also promoted the use of cell-based disease modeling and compound screening, as well as the development of gene-based therapies.

article thumbnail

ChEMBL 34 is out!

The ChEMBL-og

This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: [link] Please see ChEMBL_34 release notes for full details of (..)